Lunai Bioworks (LNAI) Asset Writedowns and Impairment (2023 - 2025)

Lunai Bioworks' Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $122.8 million for Q2 2025.

• In Q2 2025, Asset Writedowns and Impairment changed N/A year-over-year to $122.8 million; the TTM figure through Jun 2025 stood at $122.8 million (up 99.45% YoY), while the FY2025 annual figure was $122.8 million, up 188.2% from the prior year.
• Asset Writedowns and Impairment was $122.8 million for Q2 2025 at Lunai Bioworks, up from $47.6 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $122.8 million in Q2 2025 to a low of $19.0 million in Q2 2023.
• Historically, Asset Writedowns and Impairment has averaged $58.0 million across 3 years, with a median of $45.1 million in 2024.